AtriCure is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Michael H. Carrel, with a market cap of $1.4B.
Common questions about AtriCure
AtriCure is scheduled to report earnings for Q1 2026 on April 28, 2026. Analysts estimate revenue of $139.6M.
AtriCure has approximately 1,200 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.